Showing results (271-280 of 1,241) with videos related to

Sort By:
Pageof 125
Jac-Antimicrobial Resistance|May 4, 2026
Structured integration of rapid antimicrobial susceptibility testing and antimicrobial resistance detection into an antimicrobial stewardship programme for bacteraemiaAna Verónica Halperin, Sara Gómez-León, Rosa Escudero-Sánchez, et al.
Jac-Antimicrobial Resistance|June 5, 2026
Carbapenem resistance in community-acquired urinary tract infections caused by Klebsiella pneumoniae and Escherichia coli in Morocco: a multicentre study (January 2022-December 2023): 'Carbapenem resistance in community UTIs in Morocco'Aboubakr Khazaz, Fatima El Otmani, Ihssane Benzaarate, et al.
Jac-Antimicrobial Resistance|June 26, 2023
Understanding patient and healthcare worker experiences and perspectives of multidrug-resistant organismsEliza Watson, Tess Tsindos, Anton Y Peleg, et al.
Jac-Antimicrobial Resistance|August 3, 2023
Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH studyIoannis Baltas, Mark Gilchrist, Eirini Koutoumanou, et al.
Jac-Antimicrobial Resistance|June 16, 2023
Outcome, risk factors and therapeutic strategies in carbapenem-resistant Gram-negative bacteraemia from PakistanMehreen Fatima, Sunil Kumar Dodani, Zaheer Udin Babar, et al.
Jac-Antimicrobial Resistance|April 2, 2026
Carbapenem and colistin-resistant Klebsiella pneumoniae co-producing NDM-5 and OXA-48 in a teaching hospital from TunisiaNadia Jaidane, Wejdene Mansour, Saoussen Oueslati, et al.
Jac-Antimicrobial Resistance|April 30, 2026
Antibiotic prescribing by non-medical healthcare professionals in primary care: a systematic review of effects on antibiotic use, patient experience, interprofessional relationships and job satisfactionHenry Veillard, Mirza Lalani, Nicholas Mays, et al.
Jac-Antimicrobial Resistance|April 17, 2026
UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in ScotlandCosmika Goswami, Ebru Turgal, Tanja Mueller, et al.
Jac-Antimicrobial Resistance|April 15, 2026
Recurrent infections caused by ESBL-producing enterobacterales with or without subsequent development of distinct carbapenem-resistant phenotypes: differential driving factors and impact on outcomeDanielle Kruse, Pamela Ny, Paul Nieberg, et al.
Jac-Antimicrobial Resistance|June 18, 2026
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA studyEmre Yücel, Alex Soriano, Florian Thalhammer, et al.
Pageof 125